Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Biochim Biophys Acta ; 1308(3): 256-62, 1996 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-8809118

RESUMO

The in vitro relationship between eukaryotic DNA polymerases and fatty acids was investigated. Some fatty acids strongly inhibited the activities of DNA polymerase alpha and/or beta in vitro. The kinetics of inhibition by linoleic acid showed that DNA polymerase alpha was non-competitively inhibited with respect to the DNA template and substrate (dTTP), while DNA polymerase beta was inhibited competitively with both DNA and substrate.


Assuntos
Ácidos Graxos/farmacologia , Inibidores da Síntese de Ácido Nucleico , Animais , Bovinos , DNA Polimerase I/antagonistas & inibidores , DNA Polimerase I/metabolismo , DNA Polimerase II/antagonistas & inibidores , DNA Polimerase II/metabolismo , DNA Polimerase Dirigida por DNA/metabolismo , Detergentes/farmacologia , Ácidos Graxos/química , Cinética , Ácido Linoleico , Ácidos Linoleicos/farmacologia , Octoxinol , Polietilenoglicóis/farmacologia , Ratos , Nucleotídeos de Timina/metabolismo
2.
Neoplasma ; 44(2): 91-5, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9201287

RESUMO

Aphidicolin is a tetracyclic diterpene antibiotic which kills human neuroblastoma cells (NB) in vitro while it has no significant effect on the viability of different human cell types including normal embryonal cells. In the present study, we tested whether aphidicolin encapsulated in liposomes kills NB cells with the efficacy superior to that of unencapsulated aphidicolin. The drug was entrapped in vesicles composed of phosphatidylcholine, phosphatidylserine and cholesterol in a molar ratio of 83:5:12. The treatment with encapsulated aphidicolin at a concentration of 200 nmol for 5 days killed all cells of three human NB cell lines. In contrast, at least 30% of the cells survived 5 days of treatment with 200 nmol unencapsulated aphidicolin. The results showed that aphidicolin killing of human NB cells may be increased by encapsulation in liposomes.


Assuntos
Afidicolina/farmacologia , DNA Polimerase II/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Neuroblastoma/tratamento farmacológico , Morte Celular/efeitos dos fármacos , Portadores de Fármacos , Humanos , Lipossomos , Células Tumorais Cultivadas
3.
Int J Biochem ; 25(3): 385-95, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8385031

RESUMO

1. The specific activity of DNA-polymerase alpha isolated from pSV3.neo-transformed cells was more than 9-fold higher than that of polymerase alpha from untransformed cells. 2. Western blot analysis, using anti-SV40 large T antigen, of both a crude cellular extract and of partially purified polymerase alpha from pSV3.neo-transformed cells revealed a single 76 kDa immunoreactive band not found in either crude extracts or partially purified enzyme from untransformed cells. 3. The alpha polymerases from untransformed and transformed cells differed in molecular size, sensitivity to various inhibitors, specificity of template-primer utilization, and binding affinity for DNA cellulose, but showed essentially no differences in Km or Vmax. 4. These data suggest that polymerase alpha isolated from pSV3.neo-transformed cells exhibits altered physical and catalytic characteristics compared with its untransformed cell counterpart, and that those alterations may be associated with increased replication of the genome in plasmid-transformed cells.


Assuntos
Transformação Celular Viral , DNA Polimerase II/metabolismo , Fibroblastos/enzimologia , Vírus 40 dos Símios , Idoso , Antígenos Transformantes de Poliomavirus/análise , Antígenos Transformantes de Poliomavirus/metabolismo , Western Blotting , Catálise , Divisão Celular , Linhagem Celular Transformada , Celulose/análogos & derivados , Celulose/metabolismo , DNA/metabolismo , DNA Polimerase II/antagonistas & inibidores , DNA Polimerase II/química , Humanos , Peso Molecular , Vírus 40 dos Símios/imunologia , Moldes Genéticos
4.
Biochem J ; 362(Pt 3): 685-92, 2002 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-11879196

RESUMO

Polyacetylenetriol (PAT), a natural marine product from the Mediterranean sea sponge Petrosia sp., was found to be a novel general potent inhibitor of DNA polymerases. It inhibits equally well the RNA- and DNA-dependent DNA polymerase activities of retroviral reverse transcriptases (RTs) (i.e. of HIV, murine leukaemia virus and mouse mammary tumour virus) as well as cellular DNA polymerases (i.e. DNA polymerases alpha and beta and Escherichia coli polymerase I). A study of the mode and mechanism of the polymerase inhibition by PAT has been conducted with HIV-1 RT. PAT was shown to be a reversible non-competitive inhibitor. PAT binds RT independently and at a site different from that of the primer-template and dNTP substrates with high affinity (K(i)=0.51 microM and K(i)=0.53 microM with dTTP and with dGTP as the variable substrates respectively). Blocking the polar hydroxy groups of PAT has only a marginal effect on the inhibitory capacity, thus hydrophobic interactions are likely to play a major role in inhibiting RT. Preincubation of RT with the primer-template substrate prior to the interaction with PAT reduces substantially the inhibition capacity, probably by preventing these contacts. PAT does not interfere with the first step of polymerization, the binding of RT to DNA, nor does the inhibitor interfere with the binding of dNTP to RT/DNA complex, as evident from the steady-state kinetic study, whereby K(m) remains unchanged. We assume, therefore, that PAT interferes with subsequent catalytic steps of DNA polymerization. The inhibitor may alter the optimal stereochemistry of the polymerase active site relative to the primer terminus, bound dNTP and the metal ions that are crucial for efficient catalysis or, alternatively, may interfere with the thumb sub-domain movement and, thus, with the translocation of the primer-template following nucleotide incorporation.


Assuntos
Acetileno/farmacologia , Transcriptase Reversa do HIV/antagonistas & inibidores , Inibidores da Síntese de Ácido Nucleico , Polímeros/farmacologia , DNA Polimerase Dirigida por RNA/metabolismo , Inibidores da Transcriptase Reversa/farmacologia , Acetileno/análogos & derivados , Alcinos , Animais , Sequência de Bases , DNA Polimerase I/antagonistas & inibidores , DNA Polimerase II/antagonistas & inibidores , Escherichia coli/enzimologia , HIV-1/enzimologia , Humanos , Cinética , Vírus da Leucemia Murina/enzimologia , Vírus do Tumor Mamário do Camundongo/enzimologia , Camundongos , Dados de Sequência Molecular , Oligodesoxirribonucleotídeos/química , Oligodesoxirribonucleotídeos/metabolismo , Poli-Inos
5.
Biochemistry ; 34(45): 14741-51, 1995 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-7578082

RESUMO

Of the various cell types in the life cycle of Physarum polycephalum, only the growing plasmodium contains the unusual polyester beta-poly(L-malate). The nuclei exhibit large complexes of this polymer with nuclear proteins, among them DNA polymerase alpha, histones, and HMG-like proteins. The complexes are indicated by the results of size exclusion chromatography and chemical cross-linking with 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride (EDC). After hydroxylaminolysis of the cross-linked polyester, the proteins are liberated and visualized on Western blots. The complexes of 1200-1400 kDa molecular mass exceed by far the size of free beta-poly(L-malate) and proteins. The observed variation in mass appears to be mainly a function of the kind and stoichiometry of the protein constituents and may explain the relatively high molecular mass in S phase and the low molecular mass during G2 phase of the mitotic cycle. The complexes are considerably stable at moderate ionic strength (100 mM KCl). Also, endogenous beta-poly(L-malate) does not exchange with added beta-[14C]poly(L-malate) during the lysis of the nuclei and the sample preparation. The complexes are dissociated at elevated concentrations of KCl, in the presence of spermine hydrochloride, or by treatment with DEAE/cellulose. Available evidence indicates that beta-poly(L-malate) may be involved in the maintenance of the plasmodial state of P. polycephalum.


Assuntos
DNA Polimerase II/metabolismo , Histonas/metabolismo , Malatos/química , Proteínas Nucleares/metabolismo , Physarum polycephalum/química , Polímeros/química , Animais , Ciclo Celular , Núcleo Celular/química , Núcleo Celular/metabolismo , Cromatografia em Agarose , Reagentes de Ligações Cruzadas , DNA Polimerase II/antagonistas & inibidores , DNA Polimerase II/química , Eletroforese em Gel de Poliacrilamida , Etildimetilaminopropil Carbodi-Imida , Proteínas de Grupo de Alta Mobilidade/metabolismo , Histonas/química , Hidroxilamina , Hidroxilaminas/farmacologia , Malatos/metabolismo , Mitose , Peso Molecular , Proteínas Nucleares/química , Polímeros/metabolismo , Cloreto de Potássio/farmacologia , Ligação Proteica , Espermina/farmacologia
6.
Res Commun Mol Pathol Pharmacol ; 92(2): 165-76, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8774070

RESUMO

The mechanism of antitumor action of zinostatin stimalamer (YM881) was studied. YM881 suppressed colony formation of HeLa cells dose-dependently, and showed cytocidal activity. The compound inhibited DNA synthesis, but neither RNA nor protein synthesis in L1210 cells, and induced cellular DNA strand breaks in HeLa cells and DNA cleavage of PM2 phage supercoiled DNA. The compound was also shown to cause typical G2/M phase arrest in the L1210 cell cycle, and inhibited activity of DNA polymerase alpha of HeLa cells, but only at a high concentration. These results suggest that the antitumor and cytotoxic mechanisms of YM881 are identical to those of neocarzinostatin (NCS), and were due to cellular DNA strand breaks induced by direct DNA-cleaving activity and the subsequent inhibition of DNA synthesis.


Assuntos
Antineoplásicos/farmacologia , Anidridos Maleicos/farmacologia , Poliestirenos/farmacologia , Zinostatina/análogos & derivados , Animais , Antibióticos Antineoplásicos/farmacologia , Ciclo Celular/efeitos dos fármacos , DNA Polimerase I/antagonistas & inibidores , DNA Polimerase II/antagonistas & inibidores , DNA de Neoplasias/biossíntese , DNA de Neoplasias/metabolismo , DNA Super-Helicoidal/biossíntese , DNA Super-Helicoidal/metabolismo , Ensaios de Seleção de Medicamentos Antitumorais , Inibidores Enzimáticos/farmacologia , Células HeLa , Humanos , Leucemia L1210/tratamento farmacológico , Leucemia L1210/metabolismo , Camundongos , Proteínas de Neoplasias/biossíntese , Células-Tronco Neoplásicas/efeitos dos fármacos , RNA Neoplásico/biossíntese , Zinostatina/farmacologia
7.
Am J Hematol ; 36(2): 100-4, 1991 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1707224

RESUMO

Phosphatidylinositol (PI) liposomes at 40 microM increased tissue plasminogen activator (t-PA) biosynthesis by human fetal lung fibroblasts IMR-90 (FLF), after 5 days of incubation by 7.4 +/- 1.4 times of the control level. Other phospholipid liposomes, such as phosphatidylserine (PS), phosphatidylcholine (PC), and phosphatidylglycerol (PG), had no effect on t-PA biosynthesis by FLF. The induction of t-PA biosynthesis by PI liposomes was inhibited by specific inhibitors of phosphoinositide pathway: gentamycin and lithium chloride. Thus, gentamycin inhibited the effect of PI liposomes on t-PA biosynthesis by 76% (P less than 0.001), while it had no effect on control FLF. Likewise, lithium chloride inhibited t-PA biosynthesis of both PI-treated and control FLF by greater than 84%. The induction of t-PA biosynthesis by PI liposomes was dependent on RNA transcription and independent of DNA biosynthesis.


Assuntos
Fibroblastos/metabolismo , Pulmão/embriologia , Fosfatidilinositóis/administração & dosagem , Ativador de Plasminogênio Tecidual/biossíntese , Afidicolina , Células Cultivadas , Cloretos/farmacologia , DNA/biossíntese , DNA/efeitos dos fármacos , DNA Polimerase II/antagonistas & inibidores , Diterpenos/farmacologia , Portadores de Fármacos , Feto/metabolismo , Gentamicinas/metabolismo , Humanos , Hidroxiureia/farmacologia , Lipossomos , Lítio/farmacologia , Cloreto de Lítio , Pulmão/citologia , Pulmão/metabolismo , Fosfatidilinositóis/farmacologia , RNA/biossíntese , RNA/efeitos dos fármacos , Ativador de Plasminogênio Tecidual/genética , Transcrição Gênica/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA